BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
0.6450
04-October-24 14:59:50
15 minutes delayed
Stocks
+0.0050
+0.78%
Today's range
0.6301 - 0.6600
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
17 May 2024 08:47:43 By NetDania Notify
-
NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
16 May 2024 14:18:13 By NetDania Notify
-
NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
15 May 2024 09:16:14 By NetDania Notify
-
14 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
21 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
27 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
05 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
30 Nov 2023 14:03:02 By NetDania Notify
-
NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
20 Nov 2023 14:31:57 By NetDania Notify
-
Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
09 Nov 2023 15:05:01 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
07 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
18 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
17 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
16 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers
28 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
12 Sep 2023 07:05:25 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Participate in September Investor Conferences
05 Sep 2023 15:15:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
07 Aug 2023 15:10:00 By Nasdaq GlobeNewswire
-
03 Aug 2023 06:30:00 By Nasdaq GlobeNewswire